# Cell-free Stem Cell-derived Extract Formulation for Knee Osteoarthritis

> **NCT04971798** · EARLY_PHASE1 · UNKNOWN · sponsor: **General Therapeutics** · enrollment: 12 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** Cell-free Stem Cell-derived Extract Formulation (CCM)

## Key facts

- **NCT ID:** NCT04971798
- **Lead sponsor:** General Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04971798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04971798, "Cell-free Stem Cell-derived Extract Formulation for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04971798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*